Product Details
This daily electronic briefing delivers coverage of what’s happening on Capitol Hill and at the FDA, FTC, HHS, NIH and other key agencies and decision-making bodies that affect the pharmaceutical industry. Each issue gives you hard reporting on top issues, such as drug-safety oversight, clinical trial registries, adverse event reporting and warning letters. Written by FDAnews’ veteran staff of reporters, you get the news as it happens with the added perspective that only seasoned reporters can provide. It’s the fastest, most reliable way to make sure you’re an industry expert.Daily, 30-day electronic trial subscription